Minutes of the PRAC meeting 4-7 March 2024
Submitted by Anonymous (not verified) on 14 May 2024 - 13:24
Minutes of the PRAC meeting 4-7 March 2024
Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1
Submitted by Anonymous (not verified) on 14 May 2024 - 11:11
Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1
On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services
Submitted by Anonymous (not verified) on 14 May 2024 - 10:00
On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services
Products Management Services - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe: Introduction - EU Implementation Guide
Submitted by Anonymous (not verified) on 14 May 2024 - 8:48
Products Management Services - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe: Introduction - EU Implementation Guide
Agenda of the PRAC meeting 13-16 May 2024
Submitted by Anonymous (not verified) on 13 May 2024 - 15:45
Agenda of the PRAC meeting 13-16 May 2024
Human medicines European public assessment report (EPAR): Ghryvelin (previously Macimorelin Aeterna Zentaris), macimorelin, Date of authorisation: 11/01/2019, Revision: 5, Status: Authorised
Submitted by Anonymous (not verified) on 13 May 2024 - 15:13
Human medicines European public assessment report (EPAR): Ghryvelin (previously Macimorelin Aeterna Zentaris), macimorelin, Date of authorisation: 11/01/2019, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 10, Status: Authorised
Submitted by Anonymous (not verified) on 13 May 2024 - 15:04
Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Onglyza, saxagliptin, Date of authorisation: 30/09/2009, Revision: 23, Status: Authorised
Submitted by Anonymous (not verified) on 13 May 2024 - 14:14
Human medicines European public assessment report (EPAR): Onglyza, saxagliptin, Date of authorisation: 30/09/2009, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Rasagiline Mylan, rasagiline, Date of authorisation: 04/04/2016, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 13 May 2024 - 14:01
Human medicines European public assessment report (EPAR): Rasagiline Mylan, rasagiline, Date of authorisation: 04/04/2016, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Plerixafor Accord, plerixafor, Date of authorisation: 16/12/2022, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 13 May 2024 - 13:30
Human medicines European public assessment report (EPAR): Plerixafor Accord, plerixafor, Date of authorisation: 16/12/2022, Revision: 2, Status: Authorised